FREE MEMBERSHIP Includes » ABL Advisor eNews + iData Blasts | JOIN NOW ABLAdvisor Gray ABLAdvisor Blue
Skip Navigation LinksHome / ...

ABL Advisor Search Results

News Stories (20 Results) - Biopharmaceuticals

Clovis Oncology, a biopharmaceutical company focused on acquiring, developing, and commercializing innovative anti-cancer agents in the U.S., Europe, and additional international markets, announced that it and certain of its subsidiaries... Read Story
December 12, 2022, 08:00 AM

Provention Bio, a biopharmaceutical company dedicated to intercepting and preventing immune-mediated diseases, secured a term loan facility of up to $125 million with Hercules Capital.The term loan facility provides for up to $125 million of term... Read Story
September 01, 2022, 07:50 AM

Savara, a clinical stage biopharmaceutical company focused on rare respiratory diseases, entered into a term loan agreement of $26.5 million with Silicon Valley Bank to replace its existing credit facility with the bank. The new facility represents a... Read Story
April 25, 2022, 07:29 AM

Xeris Biopharma Holdings entered into a senior secured term loan agreement with funds managed by Hayfin Capital Management to provide Xeris with up to a total of $150 million of capital.Under the terms of the debt facility, Xeris drew down $100... Read Story
March 10, 2022, 07:49 AM

Mustang Bio, a clinical-stage biopharmaceutical company announced completion of a $75 million long-term debt facility with Runway Growth Capital, a leading provider of growth loans to both venture and non-venture backed companies seeking an... Read Story
March 09, 2022, 07:51 AM

Amryt, a global, commercial-stage biopharmaceutical company secured $125 million of senior credit facilities from funds managed by the Credit Group of Ares Management Corporation. Amryt will use a portion of the proceeds to refinance its previous... Read Story
February 23, 2022, 07:18 AM

Liquidia Corporation closed a debt facility on January 7, 2022, with Silicon Valley Bank (SVB) which provides Liquidia with up to $40.0 million in term loans of which the first $20.0 million was funded at closing. Liquidia initially entered a debt... Read Story
January 10, 2022, 08:00 AM

Corium, a commercial-stage biopharmaceutical company leading the development and commercialization of novel central nervous system (CNS) therapies, closed on a $235 million term loan agreement with Hercules Capital. Corium will receive an initial... Read Story
September 29, 2021, 07:32 AM

Aptinyx, a clinical-stage biopharmaceutical company developing transformative therapies for the treatment of brain and nervous system disorders, entered into a $50 million loan facility and security agreement with K2 HealthVentures (K2HV). The funds... Read Story
September 16, 2021, 07:42 AM

Analysis by Tiger Liquidity Services Biopharma Partnership underscores the strategic value to hedge funds, private equity firms, asset-based lenders, and bankruptcy professionals of leveraging asset-valuation and disposition in the... Read Story
June 02, 2020, 09:05 AM

Aimmune Therapeutics, Inc., a biopharmaceutical company developing treatments for potentially life-threatening food allergies, announced that it has entered into a $170 million loan agreement with an affiliate of KKR, a leading global investment firm... Read Story
January 07, 2019, 07:20 AM

Tiger Group and Liquidity Services, Inc. announced the launch of a partnership focused on rapid, efficient and high-recovery disposition of assets from distressed organizations in the biopharmaceutical manufacturing industry. Tiger Liquidity... Read Story
November 14, 2018, 08:13 AM

Achaogen, Inc., a late-stage biopharmaceutical company developing innovative antibacterials addressing multi-drug resistant (MDR) gram-negative infections, has entered into a new secured credit facility with Silicon Valley Bank (SVB), the bank of the... Read Story
March 02, 2018, 07:16 AM

Wells Fargo Securities, the investment banking and capital markets business of Wells Fargo & Company, announced that Andrew Singer has joined as managing director focused on the biopharmaceutical industry. He will be based in San Francisco. “We are... Read Story
November 15, 2017, 07:25 AM

Motif Bio plc, a clinical stage biopharmaceutical company specializing in developing novel antibiotics, announced that the company has entered into an agreement for up to $20 million in debt financing with Hercules Capital, Inc. a provider of debt... Read Story
November 15, 2017, 07:01 AM

Sarepta Therapeutics, Inc., a U.S. commercial-stage biopharmaceutical company focused on the discovery and development of unique RNA-targeted therapeutics for the treatment of rare neuromuscular diseases, announced that it has entered into credit and... Read Story
July 19, 2017, 07:00 AM

Square 1 Bank, a division of Pacific Western Bank, announced that it has provided a $15 million credit facility to new client Unum Therapeutics, a clinical stage biopharmaceutical company developing cellular immunotherapies for the treatment of many... Read Story
March 15, 2017, 07:39 AM

CytRx Corporation, a biopharmaceutical research and development company specializing in oncology,  has entered into a long-term loan and security agreement with Hercules Technology Growth Capital, Inc. and Hercules Technology III, L.P. for up to $40... Read Story
February 09, 2016, 07:27 AM

Omeros Corporation closed a senior credit facility with Oxford Finance and MidCap Financial consisting of a $32 million term loan, which requires interest-only payments through March 2015. Thereafter, monthly principal and interest payments will be... Read Story
March 06, 2014, 07:14 AM

ADMA Biologics, Inc. announced it has secured a loan commitment for up to $15 million from Hercules Technology Growth Capital, Inc., a leading specialty finance company focused on providing senior secured loans to venture capital-backed companies in... Read Story
February 28, 2014, 07:19 AM